Lack of Synergistic Effects of Metabolic Syndrome and Plasma Fibrinogen on Coronary Events and Mortality in Moderate CKD

Inflammation is associated strongly with metabolic syndrome in patients with moderate CKD. Inflammation and metabolic syndrome have additive and not multiplicative joint effects on coronary events and death.